XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Mar. 31, 2017
Dec. 31, 2016
Current Assets    
Cash and cash equivalents $ 11,708 $ 6,515
Short-term investments 3,541 7,826
Accounts receivable (net of allowance for doubtful accounts of $195 in 2017 and 2016) 7,066 7,018
Inventories (excludes inventories of $1,090 in 2017 and $1,117 in 2016 classified in Other assets - see Note 5) 5,146 4,866
Other current assets 4,069 4,389
Total current assets 31,530 30,614
Investments 11,896 11,416
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,171 in 2017 and $15,749 in 2016 12,042 12,026
Goodwill 18,358 18,162
Other Intangibles, Net 16,863 17,305
Other Assets 5,872 5,854
Total Assets 96,561 95,377
Current Liabilities    
Loans payable and current portion of long-term debt 5,037 568
Trade accounts payable 2,484 2,807
Accrued and other current liabilities 8,658 10,274
Income taxes payable 2,330 2,239
Dividends payable 1,314 1,316
Total current liabilities 19,823 17,204
Long-Term Debt 23,437 24,274
Deferred Income Taxes 4,889 5,077
Other Noncurrent Liabilities 8,324 8,514
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016 1,788 1,788
Other paid-in capital 39,899 39,939
Retained earnings 44,387 44,133
Accumulated other comprehensive loss (5,080) (5,226)
Stockholders' equity before deduction for treasury stock 80,994 80,634
Less treasury stock, at cost: 836,667,641 shares in 2017 and 828,372,200 shares in 2016 41,157 40,546
Total Merck & Co., Inc. stockholders’ equity 39,837 40,088
Noncontrolling Interests 251 220
Total equity 40,088 40,308
Liabilities and Equity $ 96,561 $ 95,377